People Background Check
Find People:

David C Dreyfus, Age 454 Lessay, Newport Beach, CA 92657

Get Report
Known as:
Dave Dreyfus
Related to:
Sandra Rle Dreyfus Elaine D Dreyfus 63

David Dreyfus Phones & Addresses

1008 Buckingham Ln, Newport Beach, CA 92660

Newport Coast, CA

Aliso Viejo, CA

Santa Monica, CA

10122 Town Walk Dr, Hamden, CT 06518 (203) 230-5841 (203) 230-8709

New Haven, CT

Randolph, MA

Newington, CT

Show more

Work

Company: Center/Allergy Asthma/Immu Address: 680 S Main St Suite 204, Cheshire, CT 06410 Phones: (203) 755-7080 (Phone)

Education

School / High School: Albert Einstein College of Medicine of Yeshiva University 1990

Languages

English • Spanish

Awards

Healthgrades Honor Roll

Ranks

Certificate: Allergy & Immunology, 1995

Mentions for David C Dreyfus

Career records & work history

Lawyers & Attorneys

David Dreyfus Photo 1

David Bryan Dreyfus, Los Angeles CA - Lawyer

Address:
7920 Sunset Blvd, Los Angeles, CA 90046
(310) 289-2012 (Office)
Licenses:
California - Active 1998
Education:
Ohio State University Moritz College of Law
Miami University of Ohio
Specialties:
Employment / Labor - 100%
David Dreyfus Photo 2

David Dreyfus - Lawyer

Specialties:
Labor & Employment, Intellectual Property
ISLN:
913275823
Admitted:
1998
University:
Miami University, B.A., 1995
Law School:
Ohio State University College of Law, J.D., 1998

Medicine Doctors

David Dreyfus Photo 3

Dr. David H Dreyfus, Cheshire CT - MD (Doctor of Medicine)

Specialties:
Pediatrics
Allergy & Immunology
Address:
Center/Allergy Asthma/Immu
680 S Main St Suite 204, Cheshire, CT 06410
(203) 755-7080 (Phone)
Center Allergy Asthma/Immunolgy
1389 W Main St Suite 205, Waterbury, CT 06708
(203) 755-7080 (Phone)
Certifications:
Allergy & Immunology, 1995
Pediatrics, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Spanish
Hospitals:
Center/Allergy Asthma/Immu
680 S Main St Suite 204, Cheshire, CT 06410
Center Allergy Asthma/Immunolgy
1389 W Main St Suite 205, Waterbury, CT 06708
Saint Mary's Hospital at Amsterdam
427 Guy Parks Avenue, Amsterdam, NY 12010
Waterbury Hospital
64 Robbins Street, Waterbury, CT 06708
Education:
Medical School
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1990

David H. Dreyfus

Specialties:
Allergy & Immunology
Work:
Gesher Allergy Asthma & Immunology
4 Clifton Ave, Waterbury, CT 06710
(203) 527-8172 (phone) (203) 889-0991 (fax)
Gesher Allergy Asthma & Immunology
1101 Whalley Ave, New Haven, CT 06515
(203) 527-8172 (phone) (203) 889-0991 (fax)
Education:
Medical School
Albert Einstein College of Medicine at Yeshiva University
Graduated: 1990
Procedures:
Allergen Immunotherapy, Allergy Testing, Pulmonary Function Tests
Conditions:
Bronchial Asthma, Contact Dermatitis, Allergic Rhinitis, Atopic Dermatitis, Chronic Sinusitis
Languages:
English, Spanish
Description:
Dr. Dreyfus graduated from the Albert Einstein College of Medicine at Yeshiva University in 1990. He works in New Haven, CT and 1 other location and specializes in Allergy & Immunology. Dr. Dreyfus is affiliated with Midstate Medical Center, Saint Marys Hospital, Waterbury Hospital and Yale New Haven Hospital.
David Dreyfus Photo 4

David Harry Dreyfus, Waterbury CT

Specialties:
Allergist
Address:
1389 W Main St, Waterbury, CT 06708
Education:
Doctor of Medicine
Board certifications:
American Board of Allergy and Immunology Certification in Allergy and Immunology
American Board of Pediatrics Certification in Pediatrics

License Records

Medical Doctor

Address:
488 Norton Pkwy, New Haven, CT 06511
Licenses:
License #: 33246 - Expired
Issued Date: Jan 20, 1994
Renew Date: May 31, 2001
Expiration Date: May 31, 2001
Type: Physician

Publications & IP owners

Us Patents

Nuclease Resistant External Guide Sequences For Treating Inflammatory And Viral Related Respiratory Diseases

US Patent:
7928216, Apr 19, 2011
Filed:
Apr 29, 2005
Appl. No.:
11/118875
Inventors:
David H. Dreyfus - New Haven CT, US
Assignee:
Yale University - New Haven CT
International Classification:
C07H 21/04
A61K 31/715
US Classification:
536 245, 514 44
Abstract:
External Guide Sequence (EGS) are described that target proteins required for generation and modification of the immunoglobulin and T-cell repertoire that are useful for treatment or prevention of inflammatory or related diseases. Formulations suitable for administration of an EGS for treatment of inflammatory or related disease are described. The formulations may be administered via inhalation, injection, or orally. The formulations may be in the form of an ointment, lotion, cream, gel, drop, suppository, spray, liquid, powder, granule, solution, suspension, capsule, or tablet. Methods of treating inflammatory or related diseases by administering an effective amount of an EGS in a pharmaceutically acceptable carrier are also described. In preferred embodiments, the disease is asthma, allergic rhinitis, food allergies, atopic skin disease such as eczema, IL-4 and/or IL-13 dependent malignancies, IL-4 and/or IL-13 dependent autoimmune diseases, atopic diseases, the flu, and diseases caused by IL-4 dependent replication of viruses.

Targeting Of Rna With External Guide Sequences

US Patent:
2010029, Nov 18, 2010
Filed:
Aug 22, 2008
Appl. No.:
12/671498
Inventors:
David H. Dreyfus - New Haven CT, US
Lucy Y. Ghoda - San Francisco CA, US
International Classification:
C40B 30/06
C07H 21/00
C12N 15/64
C12N 15/63
C40B 40/08
C12N 1/21
C12N 5/10
US Classification:
506 10, 536 231, 435440, 4353201, 506 17, 4352523, 435419, 435348
Abstract:
The present disclosure provides compositions and methods for modulating gene expression by using EGS to target miRNA. Another aspect of the present disclosure is the use of EGS to target mitochondrial RNA. MiRNA targets may include immature or mature forms of miRNA, such as miRNA overexpressed in diseases such as cancer.

Nuclease Resistant External Guide Sequences For Treating Inflammatory And Viral Related Respiratory Diseases

US Patent:
2011019, Aug 11, 2011
Filed:
Apr 4, 2011
Appl. No.:
13/066021
Inventors:
David H. Dreyfus - New Haven CT, US
Assignee:
Yale University - New Haven CT
International Classification:
A61K 31/7088
A61P 29/00
A61P 11/00
US Classification:
514 44 A
Abstract:
External Guide Sequence (EGS) are described that target proteins required for generation and modification of the immunoglobulin and T-cell repertoire that are useful for treatment or prevention of inflammatory or related diseases. Formulations suitable for administration of an EGS for treatment of inflammatory or related disease are described. The formulations may be administered via inhalation, injection, or orally. The formulations may be in the form of an ointment, lotion, cream, gel, drop, suppository, spray, liquid, powder, granule, solution, suspension, capsule, or tablet. Methods of treating inflammatory or related diseases by administering an effective amount of an EGS in a pharmaceutically acceptable carrier are also described. In preferred embodiments, the disease is asthma, allergic rhinitis, food allergies, atopic skin disease such as eczema, IL-4 and/or IL-13 dependent malignancies, IL-4 and/or IL-13 dependent autoimmune diseases, atopic diseases, the flu, and diseases caused by IL-4 dependent replication of viruses.

Use Of T-Loop In Trans-Splicing Polynucleotides

US Patent:
2011023, Sep 29, 2011
Filed:
Oct 22, 2009
Appl. No.:
13/121399
Inventors:
David H. Dreyfus - New Haven CT, US
Lucy Y Ghoda - San Francisco CA, US
Bradford S. Goodwin - San Mateo CA, US
International Classification:
H04L 12/26
US Classification:
370235
Abstract:
A method of regulating data flow in a wireless communication network includes: collecting data regarding dynamic loading of sector-carrier pairs (pilots) in communication sectors of the wireless communication network; obtaining data rates for data flows of the pilots to access terminals within the wireless communication network; determining one or more pilots to use for conveying data in the wireless communication network based on the data rates and the dynamic loading; and altering data flow over the pilots by at least one of changing a data rate over at least one of the pilots or changing a combination of pilots used by the wireless communication network for conveying data to increase total data flow.

Compositions And Methods For Treating Herpes Viruses

US Patent:
2014024, Aug 28, 2014
Filed:
Jan 22, 2014
Appl. No.:
14/161203
Inventors:
- Cambridge MA, US
Kevin Bryant - Boston MA, US
David H. Dreyfus - New Haven CT, US
Assignee:
PRESIDENT AND FELLOWS OF HARVARD COLLEGE - Cambridge MA
International Classification:
A61K 31/513
A61K 31/195
A61K 31/4985
A61K 31/4375
A61K 31/437
A61K 31/47
A61K 31/4035
US Classification:
514250, 514269, 514312, 544319, 546156, 514567, 562451, 514417, 548473, 514416, 548472, 514292, 546 86, 514300, 546113, 544346, 546123, 435184, 4352351
Abstract:
Compositions and methods that are useful for the treatment of herpesvirus infection (including herpes simplex virii) are disclosed. Methods for identifying compounds useful for the treatment of herpesvirus infection are also disclosed.

Possible Relatives

Daniel E Dreyfus  Derek G Dreyfus  Edward D Dreyfus  Eric D Dreyfus  Adam Dreyfus  Jack M Dreyfus  Jean P Dreyfus  David J Last  David K Stancil  David J Stancombe 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.